Main Article Content
Background: Idiopathic Raynaud’s disease is twice common in women than their counterparts, and secondary Raynaud’s disease co-occurs with a variety of medicosurgical conditions. Both diseases are managed by several medications which are invariably associated with various adverse effects.
Objective: This study aimed to describe several standardized SPIRIT and PRISMA steps and items that help in the development of research protocol directed towards systematic review and meta-analysis conduction concerning Raynaud’s phenomenon managed by clinical acupuncture. Methods and Results: Statements, guidelines, list of items and processes related to SPIRIT and PRISMA and their extensions and updated versions are ideal methodological tools in framing Raynaud’s disease and acupuncture research protocols for scientifically conducting not only randomized controlled trials but also systematic review and meta-analysis. By extension, these methodological tools could also be applied to develop research protocols for other diseases and nontraditional treatment interventions with some modifications. A total of 53 studies were included in this study protocol.
Discussion: In line with Traditional Chinese Medicine, the pattern of Raynaud’s disease and pros and cons of medical acupuncture should make an important component of discussion, besides the details of included randomized clinical interventions in systematic review and meta-analysis, which are but not limited to treatment effects, their strengths and limitations, quality, heterogeneity and endpoints.
Conclusion: The development of research protocol for conducting systematic review and meta-analysis is an art and while framing the draft researchers must take into account various SPIRIT and PRISMA statements and guidelines and their latest versions applicable to various diseases including Raynaud’s phenomenon managed by traditional and modern medications across the world.
Baumhäkel M, Böhm M. Recent achievements in the management of Raynaud’s phenomenon. Vascular Health Risk Management. 2010;6:207-214.
Daniels J, Pauling J, Eccleston C. Behaviour change interventions for the management of Raynaud's phenomenon: A systematic review protocol. Prospero: International Prospective Register of Systematic Reviews. 2017.
Available:https://www.crd.york.ac.uk/PROSPERO/display_record.asp? ID= CRD42017049643.
Malenfant D, Catton M, Pope JE. The efficacy of complementary and alternative medicine in the treatment of Raynaud's phenomenon: A literature review and meta-analysis. Rheumatology. 2009;48(7): 791-795.
Appiah R, Hiller S, Caspary L, Alexande K, Creutzig A. Treatment of primary Raynaud's syndrome with traditional Chinese acupuncture. Journal Internal Medicine.1997;241(2):119-124.
Rirash F, Tingey PC, Harding SE, Maxwell LJ, Ghogomu ET, Wells GA, Tugwell P, Pope J. Calcium channel blockers for primary and secondary Raynaud’s phenomenon. Cochrane Database Systematic Reviews. 2017;12.
[Art. No: CD000467]
Wigley FM, Flavahan NA. Raynaud’s phenomenon. NEJM. 2016;375:556-565.
Maverakis E, Patel F, Kronenberg D, Chung L, Fiorentino D, Allanore Y, et al. International consensus criteria for the diagnosis of Raynaud’s phenomenon. Journal Autoimmunity. 2014;0:60–65.
De La Vega AJ, Derk CT. Phosphodiesterase-5 inhibitors for the treatment of Raynaud’s: A novel indication. Expert Opinion Investigation Drugs. 2009; 18(1):23-29.
Daniels J, Pauling JD, Eccelston C. Behaviour change interventions for the management of Raynaud's phenomenon: A systematic review protocol. BMJ Open. 2017;7:e017039.
Komori M, Takada K, Tomizawa Y, Nishiyama K, Kondo I, Kawamata M, Ozaki M. Microcirculatory responses to acupuncture stimulation and phototherapy. Anesthesia Analgesia. 2009;108(2):635-640.
Donoyama N, Ohkoshi N. Electroacupuncture therapy for arthralgia and Raynaud’s phenomenon in a patient with systemic lupus erythematosus. Acupuncture Medicine. 2010;28(1):49-51.
Sang-woo Jeon, Ho Kim, Min-jeong Jeong, In-soo Jang. A Review of acupuncture for the treatment of Raynaud’s disease. Journal International Korean Medicine. 2017;38(4):433-442.
Du Yuanhao, Xiong Jun, Huang Wei, Li Bo, Shi Lei. Medical conditions treated by acupuncture: A preliminary review of randomized controlled trials. Medical Acupuncture. 2009; 21(3):207-213.
Wei Li, Ping Yin, Lixing Lao, Shifen Xu. Effectiveness of acupuncture used for the management of postpartum depression: A systematic review and meta-analysis. Bio Med Research International. 2019;8
Qureshi NA. How do you treat Raynaud’s syndrome in your practice (Clinical pearls)? Medical Acupuncture. 2019; 31(3):7.
Qureshi NA, Sharma S, Guru R, Alharbi MK. Raynaud’s disease and clinical challenges: A minireview of literature with a spotlight on acupuncture. Journal Advances Medicine Medical Research. 2019;29(7):1-10.
Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. British Medical Journal 2015;349:g7647.
Pope J, Rirash F, Tingey PC, Harding SE, Maxwell LJ, Tanjong Ghogomu E, et al. Drug interventions versus placebo for the treatment of Raynaud’s phenomenon: Generic protocol. Cochrane Database of Systematic Reviews. 2015:CD011813.
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. PRISMA Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Review. 2015;4:1.
DOI: 10. 1186/2046-4053-4-1
Moher D, Chan AW. Spirit (Standard protocol items: Recommendations for interventional trials) (Chapter 7). In: Guidelines for reporting health research: A User’s Manual; 2014.
Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, Hróbjartsson A, Schulz KF, Parulekar WR, Krleža-Jerić K. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. British Medical Journal. 2013;346:e7586.
PRISMA transparent reporting of systematic reviews and meta-analyses.
National Institute for Clinical and Health Excellence (NICE). Raynaud's phenomenon: Clinical Knowledge Summary; 2014.
Available:https://cks. nice.org.uk/raynauds-phenomenon#!topic summary
Gladue H, Maranian P, Paulus HE, Khanna D. Evaluation of test characteristics for outcome measures used in Raynaud's phenomenon clinical trials. Arthritis Care Research. 2013;65:630-636.
Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, et al. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis Rheumatology. 2002;46:2410-2420.
Zhang L, Zhang J, Chen J, Xing D, Mu W, Wang J, et al. Clinical research of traditional Chinese medicine needs to develop its own system of core outcome sets. Evidence Based Complementary Alternative Medicine. 2013;202703.
Klimek L, Bergmann KC, Biedermann T, Bousquet J, Hellings P, Jung K, Merk H, Olze H, Schlenter W, Stock P, Ring J. Visual Analogue Scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care. Allergo Journal International. 2017;26(1): 16-24.
Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual analog scale for pain (vas pain), numeric rating scale for pain (nrs pain), mcgill pain questionnaire (mpq), short-form mcgill pain questionnaire (sf-mpq), chronic pain grade scale (cpgs), short form-36 bodily pain scale (sf-36 bps), and measure of intermittent and constant osteoarthritis pain (icoap). Arthritis Care Research. 2011;63(S):S24011-52.
Castarlenas E, Jensen MP, von Baeyer CL, Miró J. Psychometric properties of the numerical rating scale to assess self-reported pain intensity in children and adolescents. Clinical Journal Pain. 2017; 33(4):376-383.
Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113:9-19.
American Classification of Pain conditions. Conditions A-Z.
Stratford PW, Binkley J, Solomon P, Finch E, Gill C, Moreland J. Defining the minimum level of detectable change for the Roland-Morris questionnaire. Physical Therapy. 1996;76(4):359-365.
Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine. 2000;25(22):2940-2952.
36-Item short form survey (SF-36).
Balestroni G, Bertolotti G. EuroQol-5D (EQ-5D): An instrument for measuring quality of life. Monaldi Archives Chest Disease. 2012;78(3):155-159.
Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, the Cochrane Collaboration; 2014.
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [Updated March 2011]. The Cochrane Collaboration; 2011.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ. GRADE Working Group. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. British Medical Journal. 2008;336(7650):924-926.
Chen H, Ning Z, Lam WL, Lam W-Y, Zhao YK, Yeung JWF, et al. Types of control in acupuncture clinical trials might affect the conclusion of the trials: A review of acupuncture on pain management. Journal Acupuncture Meridian Studies. 2016;9(5): 227-233.
Wang YR, Zhao JP, Hao DF. Is sham acupuncture a real placebo: Skeptical for sham acupuncture. World Journal Acupuncture-Moxibustion. 2017;27(2):1-5.
Kitchenham B. Procedures for performing systematic reviews. Joint Technical Report.
Airaksinen O, Brox JI, Cedraschi C, Hildebrandt J, Klaber-Moffett J, Kovacs F, et al. COST B13 Working Group on guidelines for chronic low back pain chapter 4. European guidelines for the management of chronic nonspecific low back pain. European Spine Journal. 2006; 15(Suppl 2):S192-300.
Cochrane pain, palliative & supportive care. Review group. Authoring or assessing a cochrane protocol, review or review update; 2011.
Johnston BC, Thorlund K, da Costa BR, Furukawa TA, Guyatt GH. New methods can extend the use of minimal important difference units in meta-analyses of continuous outcome measures. Journal Clinical Epidemiology. 2012;65(8):817-826.
Schmidt CO, Raspe H, Pfingsten M, Hasenbring M, Basler HD, Eich W, et al. Back pain in the German adult population: prevalence, severity and sociodemographic correlates in a multiregional survey. Spine. 2007;32(18): 2005-2011.
World Class Systematic Review management.
Van Hippel PT. The heterogeneity statistic I2 can be biased in small meta-analysis. BMC Medical Research Methodology. 2015;15:35.
Jacobson NS, Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal Consulting Clinical Psychology. 1991;59: 12-19.
Herrick AL. Pathogenesis of Raynaud's phenomenon. Rheumatology. 2005;44: 587-596.
Riley RD, Higgins JPT, Deeks JJ. Interpretation of random effects meta-analyses. British Medical Journal. 2011; 342:d549.
Calvert M, Kyte D, Mercieca-Bebber R, Slade A, Chan AW, King MT. The SPIRIT-PRO group. Guidelines for inclusion of patient-reported-outcome in clinical trial protocols, the SPIRIT-PRO Extension. JAMA. 2018;319(5):483-494.
Dai L, Cheng CW, Tian R, Zhong LLD, Li YP, Lyu AP, et al. Standard protocol items for clinical trials with Traditional Chinese Medicine 2018: recommendations, explanation and elaboration (SPIRIT-TCM Extension 2018. Chinese Journal Integrative Medicine. 2019;25(1):71-79.